These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 1820013)
1. A new synthetic protease inhibitor, E-3123, reduces organelle fragility of acinar cells in rat caerulein pancreatitis. Hirano T; Manabe T; Imanishi K; Yotsumoto F; Kyogoku T; Tobe T Nihon Geka Hokan; 1991 Nov; 60(6):406-14. PubMed ID: 1820013 [TBL] [Abstract][Full Text] [Related]
2. Protective effect of nafamostat mesilate on cellular and lysosomal fragility of acinar cells in rat cerulein pancreatitis. Manabe T; Hirano T; Imanishi K; Ando K; Yotsumoto F; Tobe T Int J Pancreatol; 1992 Oct; 12(2):167-72. PubMed ID: 1281204 [TBL] [Abstract][Full Text] [Related]
3. A new synthetic protease inhibitor, E-3123, prevents lysosomal and mitochondrial fragility in rat caerulein-induced pancreatitis. Hirano T; Manabe T J Int Med Res; 1992 Jun; 20(3):211-7. PubMed ID: 1383065 [TBL] [Abstract][Full Text] [Related]
4. Protection by a new synthetic protease inhibitor, ONO3307, of the rat exocrine pancreas during acute edematous pancreatitis induced by a supramaximal dose of caerulein in comparison with FOY007. Hirano T; Manabe T; Tobe T Pharmacology; 1992; 45(2):107-16. PubMed ID: 1381836 [TBL] [Abstract][Full Text] [Related]
5. Cytoprotective effects of prostaglandins and a new potent protease inhibitor in acute pancreatitis. Hirano T; Manabe T; Tobe T Am J Med Sci; 1992 Sep; 304(3):154-63. PubMed ID: 1282294 [TBL] [Abstract][Full Text] [Related]
6. Effect of prostaglandin E2 on cellular, lysosomal and mitochondrial fragility in caerulein-induced pancreatitis in rats. Manabe T; Hirano T; Ando K; Yotsumoto F; Tobe T Hepatogastroenterology; 1993 Oct; 40(5):463-6. PubMed ID: 8270235 [TBL] [Abstract][Full Text] [Related]
7. [Changes of parotid gland in rat caerulein-induced acute pancreatitis: study on in vitro system]. Hirano T; Manabe T; Tobe T Nihon Geka Hokan; 1990 Jul; 59(4):310-4. PubMed ID: 1718233 [TBL] [Abstract][Full Text] [Related]
8. Effect of short-term pancreatico-biliary duct obstruction with intraductal hypertension on subcellular organelle fragility and pancreatic adenylate energy metabolism in rats: protective effect of a new protease inhibitor, E-3123. Hirano T; Manabe T Acta Chir Belg; 1994; 94(2):80-5. PubMed ID: 7517090 [TBL] [Abstract][Full Text] [Related]
9. Effect of prostaglandin E on the redistribution of lysosomal enzymes in caerulein-induced pancreatitis. Hirano T; Manabe T; Yotsumoto F; Ando K; Imanishi K; Tobe T Hepatogastroenterology; 1993 Apr; 40(2):155-8. PubMed ID: 7685311 [TBL] [Abstract][Full Text] [Related]
10. [The cellular and lysosomal fragility of pancreatic acinar cells after ligation of pancreatico-biliary duct in the rat and the protective effects of nafamostat mesilate]. Hirano T; Manabe T; Tobe T Nihon Geka Gakkai Zasshi; 1992 Dec; 93(12):1489-500. PubMed ID: 1283776 [TBL] [Abstract][Full Text] [Related]
11. [Changes of lysosomal and digestive enzymes in rat caerulein pancreatitis]. Hirano T; Manabe T; Imanishi K; Tobe T Nihon Geka Hokan; 1991 Mar; 60(2):122-34. PubMed ID: 1726396 [TBL] [Abstract][Full Text] [Related]
12. Effect of short-termed pancreatico-biliary duct obstruction on lysosomal enzyme in rats: protective effect of a potent new protease inhibitor, E-3123. Hirano T; Manabe T; Yotsumoto F; Ohshio G; Nio Y Nihon Geka Hokan; 1992 May; 61(3):234-48. PubMed ID: 1280076 [TBL] [Abstract][Full Text] [Related]
13. [Changes of acinar cells in the pancreato-biliary duct ligation with exocrine pancreatic stimulation model in rats; protective effects of a new potent protease inhibitor, ONO3307]. Hirano T; Yotsumoto TM; Ando K; Tobe T Nihon Geka Hokan; 1991 Sep; 60(5):342-53. PubMed ID: 1726453 [TBL] [Abstract][Full Text] [Related]
14. Effect of hypothermia on pancreatic acinar cells in rats. Hirano T; Manabe T; Calne R; Printz H Nihon Geka Hokan; 1992 Jul; 61(4):320-33. PubMed ID: 1281973 [TBL] [Abstract][Full Text] [Related]
15. E-3123, a new synthetic protease inhibitor, protects against deoxycholic acid-induced acute pancreatitis in dogs. Iwatsuki K; Horiuchi A; Yonekura H; Ren LM; Chiba S Arch Int Pharmacodyn Ther; 1990; 308():168-77. PubMed ID: 1711836 [TBL] [Abstract][Full Text] [Related]
16. Protective effects of therapy with a protease and xanthine oxidase inhibitor in short form pancreatic biliary obstruction and ischemia in rats. Hirano T; Manabe T; Steer M; Printz H; Calne R; Tobe T Surg Gynecol Obstet; 1993 Apr; 176(4):371-81. PubMed ID: 8460415 [TBL] [Abstract][Full Text] [Related]
17. "Cocktail" therapy for acute pancreatitis: combined therapy of protease inhibitor, xanthine oxidase inhibitor and platelet activating factor antagonist in rat caerulein-induced pancreatis. Hirano T; Manabe T Nihon Geka Hokan; 1992 Nov; 61(6):433-44. PubMed ID: 1306981 [TBL] [Abstract][Full Text] [Related]
18. Cause-effect relationships between zymogen activation and other early events in secretagogue-induced acute pancreatitis. Van Acker GJ; Weiss E; Steer ML; Perides G Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1738-46. PubMed ID: 17332471 [TBL] [Abstract][Full Text] [Related]
19. Protective effects of gabexate mesilate (FOY) against impaired pancreatic energy metabolism in rat acute pancreatitis induced by caerulein. Hirano T; Manabe T; Tobe T Life Sci; 1991; 49(22):PL179-84. PubMed ID: 1719326 [TBL] [Abstract][Full Text] [Related]
20. Protective effects of prophylaxis with a protease inhibitor and a free radical scavenger against a temporary ischemia model of pancreatitis. Hirano T; Furuyama H; Kawakami Y; Ando K; Tsuchitani T Can J Surg; 1995 Jun; 38(3):241-8. PubMed ID: 7540502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]